Sure Med Compliance, an early-stage digital health firm focused on reducing the opioid-related overdose pandemic, has secured $1 million to assist fund the national launch of Perspectives in CareSM, its revolutionary platform. ProAssurance (PRA), a Birmingham-based medical professional liability company, led the pre-series A round, which included $250,000 from a state grant provided by Innovate Alabama.
Sure Med Compliance’s technology, which was founded in 2016, combines an electronic patient-reported outcome (ePRO) platform, which has been shown to improve outcomes for patients and providers in pain management settings, with a private marketplace that allows life-sciences companies to advertise their products to doctors at the point of care.
Sure Med Compliance received a National Institutes of Health Direct-to-Phase 2 SBIR funding in 2020 and initiated a clinical trial with researchers from the University of Florida’s College of Pharmacy.
Sure Med Compliance began a preliminary launch of their opioid therapy centered platform into many popular pain groups around the United States in May of this year. The company will use this financing, as well as its cooperation with ProAssurance, one of the country’s leading medical malpractice providers, to scale their risk mitigation product.
The company also intends to launch two other platforms to satisfy the needs of patients and physicians in various disease states where restricted medications are often prescribed, such as orthopedics, acute care, and addiction medicine.
